J. Robert Hariri's Insider Trades & SAST Disclosures
J. Robert Hariri's most recent trade in Celularity Inc - Ordinary Shares - Class A was a trade of 3,281 Class A Common Stock done . Disclosure was reported to the exchange on April 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Robert Hariri.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2025 | 3,281 | 21,482 | - | 0 | Class A Common Stock | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2025 | 3,281 | 3,281 | - | - | Restricted Stock Units | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.64 per share. | 13 Apr 2025 | 1,154 | 20,328 | - | 1.6 | 1,893 | Class A Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 6.48 per share. | 21 Nov 2024 | 2,500 | 20,561 (0%) | 0% | 6.5 | 16,200 | Common Stock |
| BioVie Inc | Robert J. Hariri | Director | 20 Nov 2024 | 49,800 | 49,800 | - | - | Stock Option (right to buy) | ||
| BioVie Inc | Robert J. Hariri | Director | 20 Nov 2024 | 21,815 | 21,815 | - | - | Stock Option (right to buy) | ||
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 9.46 per share. | 19 Aug 2024 | 1,000 | 23,061 (0%) | 0% | 9.5 | 9,465 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 14 Aug 2024 | 1,000 | 23,561 (0%) | 0% | 9 | 9,000 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 8.40 per share. | 14 Aug 2024 | 1,000 | 24,561 (0%) | 0% | 8.4 | 8,395 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 23,830 | 23,830 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 12,845 | 25,561 (0%) | 0% | 0 | Common Stock | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.11 per share. | 13 Apr 2024 | 1,154 | 2,855,889 | - | 4.1 | 4,743 | Class A Common Stock |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 2,937,788 | 2,937,788 | - | - | Stock Option Grant (Right to Buy) | |
| CryoPort Inc | Robert Hariri J. | Director | Sale of securities on an exchange or to another person at price $ 16.89 per share. | 14 Dec 2023 | 800 | 12,716 (0%) | 0% | 16.9 | 13,512 | Common Stock |
| CryoPort Inc | J. Robert Hariri | Director | Sale of securities on an exchange or to another person at price $ 15.50 per share. | 11 Dec 2023 | 1,000 | 13,516 (0%) | 0% | 15.5 | 15,500 | Common Stock |
| BioVie Inc | Robert Hariri J. | Director | 09 Nov 2023 | 42,254 | 42,254 (0%) | 0% | 0 | Common Stock | ||
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 15,125 | 15,125 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 8,105 | 16,016 (0%) | 0% | 0 | Common Stock | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. | 13 Apr 2023 | 11,540 | 10,148,310 | - | 0.7 | 8,241 | Class A Common Stock |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 2,084,854 | 2,084,854 | - | - | Warrants (Right to Buy) | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.83 per share. | 27 Mar 2023 | 2,084,854 | 10,159,850 | - | 0.8 | 1,739,394 | Class A Common Stock |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 30 Nov 2022 | 10,000 | 8,074,996 | - | 1.7 | 17,175 | Class A Common Stock |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 29 Nov 2022 | 40,000 | 8,064,996 | - | 1.7 | 68,400 | Class A Common Stock |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.74 per share. | 28 Nov 2022 | 40,000 | 8,024,996 | - | 1.7 | 69,600 | Class A Common Stock |
| BioVie Inc | Robert J. Hariri | Director | 23 Nov 2022 | 34,240 | 34,240 (0%) | 0% | 0 | COMMON STOCK | ||
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 119,073 | 230,287 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.87 per share. | 24 Aug 2022 | 119,073 | 7,984,996 | - | 2.9 | 341,740 | Class A Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 43.29 per share. | 11 Aug 2022 | 2,000 | 7,911 (0%) | 0% | 43.3 | 86,581 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 13,981 | 13,981 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 7,203 | 7,203 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Robert J. Hariri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 2,708 | 0 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Robert J. Hariri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 2,708 | 9,911 (0%) | 0% | - | Common Stock | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 384,801 | 384,801 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 131,234 | 7,865,923 | - | - | Class A Common Stock | |
| BioVie Inc | Robert J. Hariri | Director | 05 Apr 2022 | 122,250 | 122,250 | - | - | Stock Option (right to buy) | ||
| Celularity Inc - Ordinary ... | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 2,690,079 | 2,690,079 | - | - | Stock Option (Right to Buy) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 5,416 | 5,416 | - | - | Option to purchase common stock | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 2,708 | 2,708 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Robert J. Hariri | Director | 20 Jul 2020 | 15,300 | 0 | - | - | Warrants to purchase common stock | ||
| CryoPort Inc | Robert J. Hariri | Director | 20 Jul 2020 | 15,300 | 30,600 (0%) | 0% | 3.6 | 54,621 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges